Thomas F. Durand-Réville
Celldex Therapeutics (United States)(US)Viewpoints Research Institute(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Cyclopropane Reaction Mechanisms, Synthetic Organic Chemistry Methods, Bacterial Genetics and Biotechnology
Most-Cited Works
- → Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases(2013)350 cited
- → ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii(2017)267 cited
- → Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases(2013)219 cited
- → Rational design of a new antibiotic class for drug-resistant infections(2021)137 cited
- → Molecular Basis of Selective Inhibition and Slow Reversibility of Avibactam against Class D Carbapenemases: A Structure-Guided Study of OXA-24 and OXA-48(2014)100 cited
- → Acinetobacter baumannii OmpA Is a Selective Antibiotic Permeant Porin(2017)90 cited